Pfizer Recalls Chantix Anti-Smoking Drug Over Cancer-Causing Chemical
The voluntary recall was driven by the presence of high levels of nitrosamine, which can increase the risk of cancer. Separately, a study showed a Mirati Therapeutics drug that blocks the KRAS cancer protein shrank tumors in 22% of patients with advanced colon cancers.